News Conference News ESC 2017 CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS Todd Neale August 30, 2017
News Conference News ESC 2017 Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI Todd Neale August 27, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Daily News Lower Blood Pressure May Protect Against Cognitive Decline in Adults in Their 70s Todd Neale August 22, 2017
News Daily News Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences Todd Neale August 18, 2017
News Daily News Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared Todd Neale August 15, 2017
News Daily News Pregnancy-Associated SCAD Is a Particularly High-Risk Subset of the Condition Todd Neale July 17, 2017
News Daily News Top-Line REVEAL Results Support Efficacy of CETP Inhibition, but Questions Abound Todd Neale June 27, 2017
News Daily News CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP Todd Neale June 22, 2017
News Daily News Therapies Aimed at New Genetic Target Show Early Promise for Lowering Triglycerides Todd Neale May 26, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News Drugs Most Heavily Promoted by Pharma Don’t Necessarily Offer the Best Health Value Todd Neale May 04, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News If You Don’t Take Your Stroke Meds, This App Will Tell on You Todd Neale April 18, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics Todd Neale March 03, 2017